Total Payments
$4,783
2024 Payments
$1,067
Companies
37
Transactions
232
Medicare Patients
14,225
Medicare Billing
$1.4M
Payment Breakdown by Category
Food & Beverage$4,723 (98.7%)
Education$59.82 (1.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,723 | 226 | 98.7% |
| Education | $59.82 | 6 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $1,006 | 70 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $564.17 | 32 | $0 (2024) |
| Medtronic, Inc. | $556.57 | 9 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $363.17 | 13 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $343.75 | 23 | $0 (2024) |
| Merck Sharp & Dohme LLC | $308.18 | 15 | $0 (2024) |
| Medtronic Vascular, Inc. | $233.66 | 3 | $0 (2020) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $147.40 | 12 | $0 (2024) |
| Amgen Inc. | $141.93 | 9 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $140.94 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,067 | 48 | E.R. Squibb & Sons, L.L.C. ($287.64) |
| 2023 | $631.79 | 20 | Medtronic, Inc. ($252.02) |
| 2022 | $433.34 | 21 | Merck Sharp & Dohme LLC ($115.91) |
| 2021 | $324.66 | 18 | SANOFI-AVENTIS U.S. LLC ($81.55) |
| 2020 | $356.63 | 16 | Medtronic Vascular, Inc. ($115.01) |
| 2019 | $587.37 | 26 | E.R. Squibb & Sons, L.L.C. ($168.90) |
| 2018 | $671.39 | 35 | E.R. Squibb & Sons, L.L.C. ($153.03) |
| 2017 | $710.71 | 48 | E.R. Squibb & Sons, L.L.C. ($172.50) |
All Payment Transactions
232 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $23.31 | General |
| Category: Genetic Disease | ||||||
| 12/16/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: Cardiology | ||||||
| 12/06/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.93 | General |
| Category: Cardiovascular | ||||||
| 11/13/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $5.91 | General |
| Category: Cardiovascular | ||||||
| 10/31/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $5.43 | General |
| Category: Cardiovascular | ||||||
| 10/31/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $3.00 | General |
| Category: Cardiovascular | ||||||
| 10/24/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $118.62 | General |
| Category: Cardiovascular | ||||||
| 10/24/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $14.48 | General |
| Category: Heart Failure and Hypertension | ||||||
| 10/23/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/22/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $5.18 | General |
| Category: Cardiovascular | ||||||
| 10/21/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: Cardiology | ||||||
| 10/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.98 | General |
| Category: DIABETES | ||||||
| 09/23/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 09/10/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/03/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $24.02 | General |
| Category: Cardiovascular | ||||||
| 09/03/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $4.55 | General |
| Category: Cardiovascular | ||||||
| 08/16/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $22.66 | General |
| Category: Cardiovascular | ||||||
| 08/16/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $2.16 | General |
| Category: Cardiovascular | ||||||
| 08/15/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $24.48 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/02/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $21.70 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 08/01/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $5.75 | General |
| Category: Cardiovascular | ||||||
| 07/30/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/12/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $28.72 | General |
| Category: Cardiology | ||||||
| 07/10/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: Iron Deficiency Anemia | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 31 | 2,703 | 3,527 | $939,143 | $270,346 |
| 2022 | 31 | 3,101 | 3,932 | $1.1M | $309,557 |
| 2021 | 32 | 4,292 | 5,885 | $1.6M | $504,817 |
| 2020 | 33 | 4,129 | 5,699 | $1.2M | $354,754 |
Total Patients
14,225
Total Services
19,043
Medicare Billing
$1.4M
Procedure Codes
135
All Medicare Procedures & Services
135 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 503 | 775 | $251,875 | $71,524 | 28.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 158 | 307 | $81,355 | $29,182 | 35.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 155 | 163 | $82,478 | $22,678 | 27.5% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 175 | 175 | $86,800 | $21,527 | 24.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 160 | 160 | $67,680 | $17,687 | 26.1% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 85 | 86 | $54,094 | $14,613 | 27.0% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 85 | 87 | $41,673 | $11,334 | 27.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 128 | 154 | $28,644 | $9,661 | 33.7% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 24 | 24 | $28,272 | $7,531 | 26.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 128 | 130 | $24,633 | $6,988 | 28.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 63 | 64 | $22,400 | $6,710 | 30.0% |
| 93978 | Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | Office | 2023 | 57 | 59 | $27,494 | $6,585 | 24.0% |
| 93971 | Ultrasound study of one arm or leg veins with compression and maneuvers | Office | 2023 | 58 | 72 | $21,384 | $6,313 | 29.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 353 | 428 | $18,404 | $4,555 | 24.7% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 23 | 46 | $5,421 | $4,123 | 76.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 24 | 27 | $12,285 | $3,804 | 31.0% |
| 93975 | Complete ultrasound of abdomen and pelvis artery and vein blood flow | Office | 2023 | 20 | 20 | $13,700 | $3,763 | 27.5% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 20 | 80 | $8,640 | $2,952 | 34.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 19 | 19 | $9,690 | $2,668 | 27.5% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 174 | 353 | $3,610 | $2,259 | 62.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 35 | 37 | $8,447 | $2,097 | 24.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 20 | 20 | $5,440 | $1,836 | 33.7% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 36 | 36 | $6,372 | $1,830 | 28.7% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 21 | 21 | $8,421 | $1,816 | 21.6% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 29 | 30 | $6,030 | $1,808 | 30.0% |
About Dr. David Grech, MD
Dr. David Grech, MD is a Cardiovascular Disease healthcare provider based in Orange Park, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1336128792.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Grech, MD has received a total of $4,783 in payments from pharmaceutical and medical device companies, with $1,067 received in 2024. These payments were reported across 232 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($4,723).
As a Medicare-enrolled provider, Grech has provided services to 14,225 Medicare beneficiaries, totaling 19,043 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 135 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Cardiovascular Disease
- Location Orange Park, FL
- Active Since 01/13/2006
- Last Updated 04/15/2025
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1336128792
Products in Payments
- ELIQUIS (Drug) $681.96
- XARELTO (Drug) $564.17
- CAMZYOS (Drug) $324.38
- ENTRESTO (Drug) $307.12
- VERQUVO (Drug) $288.55
- LINQ II (Device) $276.75
- MULTAQ (Drug) $189.93
- LifeVest (Device) $147.40
- JARDIANCE (Drug) $140.94
- DISEASE STATE (Drug) $123.97
- CoreValve Evolut (Device) $118.65
- Reveal LINQ (Device) $115.01
- ONYX FRONTIER (Device) $107.35
- SYMPLICITY G3 (Device) $86.06
- SYNERGY (Device) $85.16
- NEXLETOL (Drug) $81.90
- Arcalyst (Drug) $76.25
- Corlanor (Drug) $75.99
- MICRA (Device) $74.52
- Repatha (Biological) $65.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Orange Park
Dr. Carlos Leon, Md, MD
Cardiovascular Disease — Payments: $24,484
Cardiovascular Disease $24,484
Dr. Youssef Al-Saghir, Md, MD
Cardiovascular Disease — Payments: $10,046
Cardiovascular Disease $10,046
Dr. Paul Bednarzyk, Md, MD
Cardiovascular Disease — Payments: $2,090
Cardiovascular Disease $2,090
Dr. Hossein Ramezani, M.d, M.D
Cardiovascular Disease — Payments: $446.95
Cardiovascular Disease $446.95
Dr. Jayalakshmi Padmanabhan, M.d., P.a, M.D., P.A
Cardiovascular Disease
Cardiovascular Disease